FORM 8.3 - AON PLC

FORM 8.3 - AON PLC

BARCLAYS PLC

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

	Name of person dealing (Note 1)	Barclays PLC.
	Company dealt in	AON PLC
	Class of relevant security to which the	ORD
	dealings being disclosed relate (Note 2)
	Date of dealing	07 June 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:		ORD
		Long		Short
		Number	(%)	Number	(%)
(1)	Relevant securities
		524,381	0.23%	1,910,984	0.85%
(2)	Derivatives (other than options):
		271,288	0.12%	7,021	0.00%
(3)	Options and agreements to
	purchase/sell:	24,200	0.01%	24,200	0.01%
	TOTAL:
		819,869	0.36%	1,942,205	0.86%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long			Short
	Number		(%)	Number		(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit
Purchase	7	248.3350 USD
Purchase	10	248.0500 USD
Purchase	21	249.4400 USD
Purchase	23	249.3026 USD
Purchase	27	249.1685 USD
Purchase	59	250.7628 USD
Purchase	67	247.3180 USD
Purchase	75	247.4350 USD
Purchase	91	249.5950 USD
Purchase	91	248.5220 USD
Purchase	93	248.9409 USD
Purchase	100	248.7700 USD
Purchase	100	247.1600 USD
Purchase	100	247.6100 USD
Purchase	100	247.4500 USD
Purchase	220	248.5936 USD
Purchase	238	248.2332 USD
Purchase	238	248.2333 USD
Purchase	332	248.5197 USD
Purchase	347	248.0231 USD
Purchase	483	247.9980 USD
Purchase	500	247.0130 USD
Purchase	600	247.7688 USD
Purchase	600	247.0508 USD
Purchase	663	247.3339 USD
Purchase	700	247.4700 USD
Purchase	821	248.1743 USD
Purchase	1,004	247.5754 USD
Purchase	1,214	247.6115 USD
Purchase	1,300	248.3325 USD
Purchase	1,450	247.6086 USD
Purchase	1,618	248.2075 USD
Purchase	1,989	247.5200 USD
Purchase	2,197	247.5555 USD
Purchase	2,427	247.8498 USD
Purchase	2,692	247.7812 USD
Purchase	4,513	247.8515 USD
Purchase	5,168	247.6431 USD
Purchase	6,180	247.5267 USD
Purchase	10,603	247.8122 USD
Purchase	17,317	247.5779 USD
Purchase	21,644	247.8349 USD
Sale	1	247.0700 USD
Sale	1	247.1100 USD
Sale	4	247.1450 USD
Sale	5	247.7140 USD
Sale	6	247.3216 USD
Sale	8	247.5356 USD
Sale	10	248.0500 USD
Sale	11	247.6190 USD
Sale	24	247.0800 USD
Sale	42	247.1300 USD
Sale	75	247.4350 USD
Sale	100	249.0000 USD
Sale	100	247.7100 USD
Sale	100	247.9600 USD
Sale	100	248.1100 USD
Sale	101	247.2091 USD
Sale	102	248.0650 USD
Sale	104	248.1002 USD
Sale	127	247.6333 USD
Sale	133	247.8800 USD
Sale	166	248.0000 USD
Sale	177	251.1300 USD
Sale	200	248.7475 USD
Sale	200	247.6050 USD
Sale	202	247.1640 USD
Sale	238	248.2333 USD
Sale	300	247.3433 USD
Sale	300	247.4533 USD
Sale	305	248.0322 USD
Sale	400	247.2875 USD
Sale	405	247.7040 USD
Sale	450	247.7648 USD
Sale	513	247.6676 USD
Sale	855	247.5780 USD
Sale	962	247.8490 USD
Sale	1,081	248.0495 USD
Sale	1,100	247.0336 USD
Sale	1,342	247.9008 USD
Sale	1,542	247.2935 USD
Sale	1,619	247.7468 USD
Sale	1,885	247.5200 USD
Sale	2,285	247.8739 USD
Sale	2,295	247.8167 USD
Sale	3,463	247.2947 USD
Sale	3,963	247.8769 USD
Sale	4,148	247.6489 USD
Sale	4,794	247.4410 USD
Sale	6,329	247.7437 USD
Sale	6,442	247.5967 USD
Sale	10,368	247.6491 USD
Sale	32,273	247.8600 USD

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?	YES
Date of disclosure:	8 Jun 2021
Contact name:	Large Holdings Regulatory Operations
Telephone number:	020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name	Written or	Number of	Exercise	Type	Expiry
	purchased	relevant securities	price		date
		to which the option
		or derivative
		relates
Put Options	Purchased	-1,200	220.0000	American	Jul 16, 2021
Call Options	Purchased	1,200	240.0000	American	Jul 16, 2021
Call Options	Purchased	23,000	220.0000	American	Jul 16, 2021
Put Options	Purchased	-23,000	200.0000	American	Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210608005577/en/